RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: A new principle in pharmacological vitreolysis

Current Eye Research

Volumn 25, Issue 6, 2002, Pages 333-340

  Oliveira, Leonardo B ^a   Meyer, Carsten H ^a   Kumar, Janardan ^a   Tatebayashi, Misako ^a   Toth, Cynthia A ^a,b   Wong, Fulton ^a   Epstein, David L ^a   McCuen II, Brooks W ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Integrin; Pharmacological vitreolysis; Posterior vitreous detachment; RGD peptide; Vitreoretinal interface

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPIRATION; B SCAN; CILIARY DISK; CONTROLLED STUDY; EXPERIMENTAL MODEL; EYE; NICK END LABELING; NONHUMAN; OPHTHALMOSCOPY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; RETINA CELL; SCANNING ELECTRON MICROSCOPY; VITRECTOMY; VITREOUS BODY DETACHMENT;

ANIMALS; APOPTOSIS; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON, SCANNING; OLIGOPEPTIDES; RABBITS; VITRECTOMY; VITREOUS DETACHMENT;

EID: 0038309763     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.25.6.333.14234     Document Type: Article

References (29)

1. Sebag J. Anatomy and pathology of the vitreo-retinal interface. Eye. 1992;6:541-552.
2. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Arch Ophthalmol. 1998;105:1617-1620.
3. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849-854.
4. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina. 1998;18:7-15.
5. Tanaka JM, Qui H. Pharmacological vitrectomy. Seminars Ophthalmol. 2000;15:51-61.
6. Foos RY. Vitreoretinal juncture: Topographical variations. Invest Ophthalmol Vis Sci. 1972;11:801-808.
7. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28:506-514.
8. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Invest Ophthalmol Vis Sci. 1991;32:1986-1995.
9. Jerdan JA, Gao L, Glaser BM. The inner limiting membrane: A modified basement membrane? [Abstract] Invest Ophthalmol Vis Sci. 1986;27(suppl):230.
10. Moorhead LC, Radtke N. Enzyme-assisted vitrectomy with bacterial collagenase. Pilot human studies. Retina. 1985;5:98-100.
11. Frenzel EM, Neely KA, Walsh AW, Cameron JD, Gregerson DS. A new model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1998;39:2157-2164.
12. Ingber D. Integrins as mechanochemical transducers. Current Opinion Cell Biology. 1991;3:841-848.
13. Elner SG, Elner EM. The integrin superfamily and the eye. Invest Ophthalmol Vis Sci. 1996;37:696-701.
14. Ruoslahti E. Integrins. J Clin Ivest. 1991:87:1-5.
15. Curtis TM, McKeown-Longo PJ, Vincent PA, Homan SM, Wheatley EM, Saba TM. Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-alpha 5 beta 1 or TNF-alpha exposure. Am J Physiology. 1995;269: L248-L260.
16. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697-715.
17. Gehlsen KR, Argraves WS, Pierschbacher MD, Ruoslahti E. b Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol. 1988;106:925-930.
18. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem. 1987;262:17294-17298.
19. Zhon LL, Zhang SR, Yue BYJT. Adhesions of human trabecular mashwor cells to extracellular matrix proteins. IOVS. 1996:37:104-113.
20. Williams JA. Disintegrins: RGD-containing proteins which inhibit call/matrix interactions (adhesions) cell/cell interactions (aggregation) via the integrin receptors. Pathol Biol. 1992;40:813-821.
21. Qin Z-H, Wang Y, Nakai M, Chase TN. Nuclear Factor - kB contributes to excitotoxin - induced apoptosis in rat striatum. Mol Pharmacol. 1998;53:33-42.
22. Sebag J. Pharmacologic vitreolysis [editorial]. Retina. 1998;18:1-3.
23. Brem RB, Robbins SG, Wilson DJ, O'Rourke LM, Mixon RN, Robertson JE, Planck SR, Rosenbaun JT. Immunolocalization of integrins in the human retina. Invest Ophthalmol Vis Sci. 1994;35:3466-3474.
24. Hershkovitz R, Melamed S, Greenspoon N, Lider O. Non peptidic analogues of Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human Tenon's capsule fibroblasts to fibronectin. Invest Ophthalmol Vis Sci. 1994;35:2585-2591.
25. Yang CH, Huang TF, Liu KR, Chen MS, Hung PT. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp containing peptides from viper venom. Invest Ophthalmol Vis Sci. 1996;37:843-854.
26. Cook JJ, Huang TF, Rucinski B, Strzyzewski M, Tuma RF, Williams JA, Niewiarowski S. Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. Am J Physiol. 1989;256:H1038-H1043.
27. Oliveira LB, Meyer CH, Tatebayashi M, Toth CA, Kumar J, Wong F, Epstein DL, McCuen II BW. Intravitreal injection of Arg-Gly-Asp (RGD) peptide facilitates surgical creation of posterior vitreous detachment in young pigs (Abstract). Invest Ophthalmol Vis Sci. 2001;42 (suppl):2274.
28. Matsumoto B, Blanks JC, Ryan SJ. Topographic variations in the rabbit and primate internal membrane. Invest Ophthalmol Vis Sci. 1984;25:71-82.
29. Farado MM, Deugnier MA, Lukashev M, Thiery JP, Glukhova MA. Perturbation of B1 integrin function alters the development of murine mammary gland. EMBO. 1998;17:2139-2147.